secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2024-04-04T23:59:59+00:00
Accession:  0001628280-24-014876
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Aadi Bioscience amends FYARRO supply agreement with Fresenius Kabi, extends term to July 31, 2024
--------------------------------------------------------------------------------

- Amendment effective March 31, 2024 extends supply agreement for FYARRO through July 31, 2024 (or later agreed date).
- Revised pricing, forecasting, compliance terms, and minimum purchase obligations for FYARRO from Fresenius Kabi.
- Contains other customary terms for biotech manufacturing; full amendment to be filed in subsequent periodic report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000162828024014876/0001628280-24-014876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000162828024014876/aadi-20240401.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-014876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer